Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dual-action nanotherapy: Temozolomide-loaded, anti-PD-L1 scFv-functionalized lipid nanocarriers for targeted glioblastoma therapy

European Journal of Pharmaceutical Sciences(2025)10.1016/j.ejps.2025.107255Source: DataRank Database

Dual-action nanotherapy: Temozolomide-loaded, anti-PD-L1 scFv-functionalized lipid nanocarriers for targeted glioblastoma therapy is a research paper published in European Journal of Pharmaceutical Sciences (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.93)OA: goldTopics (63)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Semer Maksoud ORCID,Bakhos A. Tannous ORCID,Sibel Bozdağ Pehlivan ORCID,Christian E. Badr ORCID,Eren Aytekin ORCID

Live enrichment

PubMed:40914463 PMC:PMC12449728 OpenAlex:https://openalex.org/W4414004413

US Department of Defense Peer Reviewed Cancer Research Program

Grant: CA191075

Türkiye Bilimsel ve Teknolojik Araştırma Kurumu

Grant: T\u00DCB\u0130TAK-2219 / 1059B192101179

National Institute of Neurological Disorders and Stroke

Grant: R01 NS113822

National Institutes of Health

Grant: 5R01NS113822-03

Role of ER stress and fatty acid metabolism in glioma stem cells

U.S. Department of Defense

National Institutes of Health

FWCI

0.93

Citation Percentile

0.7%

Influential Citations

Citation Trend

2026

goldLicense: cc-by-nc

journalhttps://doi.org/10.1016/j.ejps.2025.107255

publisherhttps://doi.org/10.1016/j.ejps.2025.107255

publisherhttps://api.elsevier.com/content/article/PII:S0928098725002532?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0928098725002532?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40914463

Fields of Study

Nanoplatforms for cancer theranosticsRNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryMedicineEngineeringMaterials Science02 engineering and technology0210 nano-technologyTemozolomideAnimalsGlioblastomaB7-H1 AntigenSingle-Chain AntibodiesBrain NeoplasmsCell Line, TumorMiceMice, Inbred C57BLNanoparticlesDrug CarriersLipidsHumansBlood-Brain BarrierAntineoplastic Agents, Alkylating

MeSH Terms

TemozolomideAnimalsBlood-Brain BarrierBrain NeoplasmsDrug CarriersGlioblastomaHumansLipidsMice, Inbred C57BLAntineoplastic Agents, AlkylatingCell Line, TumorMiceNanoparticlesSingle-Chain AntibodiesB7-H1 Antigen

Keywords

TemozolomideNanocarriersGlioblastomaPharmacologyMedicineCancer researchDrugPD-L1Nanostructured Lipid CarriersActive TargetingSingle Chain Variable Fragment (Scfv)Drug CarriersBrain NeoplasmsLipidsArticleB7-H1 AntigenMice, Inbred C57BLMiceBlood-Brain BarrierCell Line, TumorAnimalsNanoparticlesHumansAntineoplastic Agents, AlkylatingSingle-Chain Antibodies